Proterra raises $200m for Asia food fund
Proterra Investment Partners has reached a final close on a Singapore-domiciled fund that will make food-related investments across Asia with more than USD 200m in commitments.
Billed as Food Fund 3, it received backing from a mix of institutional investors, foundations, and family offices primarily from Europe and Asia. It was incorporated in Singapore in October 2020 under...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.